rs9829896 regulates OPRM1
Evidence from:
primary |
all sources
Evidence (6 sources)
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
consistency of rs9829896 association of expression across KAT2B, CREBBP, and OPRM1 among AAs
confidence: 0.80
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
rs9829896 was associated with OPRM1 expression in AAs (P=0.016)
confidence: 0.95
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
protective rs9829896-C allele was also associated with increased OPRM1 gene expression
confidence: 0.95
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
rs9829896-C allele ... increased OPRM1 expression
confidence: 0.94
KAT2B polymorphism identified for drug abuse in African Americans with regulatory links to drug abuse pathways in human prefrontal cortex.
(2016)
PMID:26202629
primary
rs9829896 as a trans-eQTL for the ... OPRM1 genes, using mRNA expression levels measured in human prefrontal cortex
confidence: 0.90
implicated rs9829896 as a cis-eQTL SNP ... for ... OPRM1
confidence: 0.90